Floatz logo

Butorphanol

Visceral Pain

Bibo WangSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Visceral Pain cohort.

Asset / SponsorPhaseRating
Cyclic Microgestin 1/20
Endeavor Health
Phase 4BB
Continuous Microgestin 1/20
Endeavor Health
Phase 4BB
Pregabalin
Parc de Salut Mar
Phase 4BB
Grta9906
Grünenthal GmbH
Phase 1CC
NALBUPHINE
Cairo University
N/AD

Same molecule, other indications

Butorphanol is also rated in:

liver and intrahepatic bile duct neoplasmDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →